Arasani, Analita A.

HRN: 12-01-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2025
CEFUROXIME 500MG (TAB)
12/01/2025
12/07/2025
PO
500MG
BID
TMSAF
Waiting Final Action 
12/01/2025
METRONIDAZOLE 500MG (TAB)
12/01/2025
12/07/2025
PO
500 MG
Q 8 HOURS
TMSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: